MacKenzie Iain sold $653K of ICHR
MacKenzie Iain sold 9,933 shares of ICHOR HOLDINGS, LTD. (ICHR) at an average of $65.76 ($65.19–$68.14, $0.65M total) across 4 trades on 2026-08-18 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale adds a data point for short‑term sentiment but is unlikely to drive significant price movement.
Market read
Primary insider sale filing; modest relevance for traders monitoring ICHOR.
What to watch
The director retained 122,427 shares, indicating continued confidence in the company.
Background
SEC Form 4 filings disclose insider transactions. This filing reports a director's open‑market sale under a 10b5‑1 plan.
Ticker impact
Director MacKenzie Iain sold 9,933 shares for $653,176 on 2026-08-18 via a 10b5‑1 plan.
Potential short‑term dip of 1‑2% as the market digests the sale.
A $653k sale by a director is a primary Form 4 disclosure but the amount is modest for a listed biotech, limiting material impact.
Market effects
Minimal effect on the broader biotech sector; insider sales are common and rarely shift sector sentiment.
No notable regional impact; the filing is specific to ICHOR.
Limited global relevance; only relevant to investors tracking ICHOR.
Counterpoint
The sale could be a routine liquidity move under a pre‑arranged plan, not a bearish signal.
Key entities
- DirectorMacKenzie Iain
Director of ICHOR Holdings who executed the sale.
- CompanyICHR
ICHOR Holdings, Ltd., a biotech listed on NASDAQ.
